SWOT Analysis for Marker Therapeutics Inc

Significant (over 30%) distance from 52 week high
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Top Gainers
Stock with Low PE (PE < = 10)

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

Promoter decreasing their shareholding
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Near 52 Week Low
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

Stocks with Quarter Change % less than Industry

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Near 52 Week Low

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Marker Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Marker Therapeutics Inc has 10 Strengths, 14 Weaknesses, 6 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Significant (over 30%) distance from 52 week high

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

Promoter decreasing their shareholding

Stocks with Quarter Change % less than Industry

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

Near 52 Week Low

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months